A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) (NCT07172516)
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
🩺 Plain-English Summary (8th-Grade Level)
X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with bipolar I or II disorder who are currently in a depressive episode (bipolar depression).
Who can join: Review the eligibility criteria below.
Location: Noble Clinical Research — Tucson, Arizona
Age range: 18 Years to 74 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- Noble Clinical Research — Tucson, Arizona
- Woodland International Research Group — Little Rock, Arkansas
- Woodland Research Northwest — Rogers, Arkansas
- Clinical Innovations Inc — Bellflower, California
- ProScience Research Group — Culver City, California
- ATP Clinical Research — Orange, California
- NRC Research Institute — Orange, California
- Clinical Innovations Inc — Riverside, California
- PharmaSouth Research, LLC — Coral Gables, Florida
- Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida
- Central Miami Medical Institute — Miami, Florida
- Clinical Neuroscience Solutions, Inc — Orlando, Florida
- Synexus Clinical Research, Inc. — Atlanta, Georgia
- Atlanta Center for Medical Research — Atlanta, Georgia
- CenExel iResearch — Decatur, Georgia
- Denali Health Atlanta, LLC — Stone Mountain, Georgia
- Advanced Quality Medical Research — Orland Park, Illinois
- Psychiatric Care and Research Center — O'Fallon, Missouri
- Redbird Clinical Research, LLC — Las Vegas, Nevada
- Lumina Clinical Research Center — Cherry Hill, New Jersey
- Integrative Clinical Trials LLC — Brooklyn, New York
- Neurobehavioral Research Inc — Cedarhurst, New York
- DelRicht Research — Charlotte, North Carolina
- Lehigh Center for Clinical Research — Allentown, Pennsylvania
- Clinical Neuroscience Solutions, Inc — Memphis, Tennessee
📞 Contact the Study Coordinator
Phone: (604) 484-3300
Email: XenonCares@xenon-pharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Bipolar Disorder
- Early Intervention for Youth at High Risk for Bipolar Disorder — Pittsburgh, Pennsylvania
- Evaluation of the Genetics of Bipolar Disorder — Bethesda, Maryland
- Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth — Toronto, Ontario
- Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression — Belmont, Massachusetts
- Characterizing MyMood Patterns of Use — Toronto, Ontario
- A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder — Boston, Massachusetts
Explore by condition: All Bipolar Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.